Show simple item record

dc.contributor.authorAsamblea Mundial de la Salud, 31
dc.coverage.spatialGinebraEN
dc.date.accessioned2014-03-13T11:34:11Z
dc.date.available2014-03-13T11:34:11Z
dc.date.issued1978
dc.identifier.govdocWHA31.32
dc.identifier.urihttps://apps.who.int/iris/handle/10665/105640
dc.description(‎12a sesión plenaria, 23 de mayo de 1978 (‎Comisión A, tercer informe)‎)‎EN
dc.language.isoesEN
dc.publisherOrganización Mundial de la SaludEN
dc.subjectPharmaceutical productsEN
dc.subjectResolutions and decisionsEN
dc.subject.meshPharmaceutical PreparationsEN
dc.subject.meshDrugs, EssentialEN
dc.subject.meshDrug and Narcotic ControlEN
dc.subject.meshProgram DevelopmentEN
dc.subject.meshProgram EvaluationEN
dc.titlePrograma de actividades en relación con los medicamentos esencialesEN
dc.typeGoverning body documentsEN
dc.subject.meshqualifierprevention and controlEN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record